Lipocine Inc.

Tickers
LPCN
Headquarters
Not recorded
SEC CIK
0001535955
Website
Not recorded

Closing prices

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

SEC filings

SEC filings from Lipocine Inc., newest first
FormFiledWhat it coversDocument
8-K Current report (8-K)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 20 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-047693 (opens in a new tab)
8-K Current report (8-K)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 7 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-046060 (opens in a new tab)
4Event 29 Sep 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 1 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-045400 (opens in a new tab)
4Event 28 Sep 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 30 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-045185 (opens in a new tab)
8-K Current report (8-K)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 16 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-042933 (opens in a new tab)
8-K Current report (8-K)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 14 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-042466 (opens in a new tab)
8-KEvent 8 Sep 2026 Current report (8-K)
  • Other events (Item 8.01)
View Current report (8-K) filed 11 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-042286 (opens in a new tab)
8-K Current report (8-K)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 10 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-042052 (opens in a new tab)
8-K/AEvent 3 Aug 2026 Amended current report (8-K/A)
  • Departure or appointment of directors or officers (Item 5.02)
View Amended current report (8-K/A) filed 21 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-039689 (opens in a new tab)
4Event 3 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 7 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001493152-26-036577 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
1 transaction, 12,561 shares, $27,131.76
Sells code S
None in this period
Other all other codes
None in this period

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.